Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,506 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetic Drug-Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil.
McCrea JB, Macha S, Adedoyin A, Marshall W, Menzel K, Cho CR, Liu F, Zhao T, Levine V, Kraft WK, Yoon E, Panebianco D, Stoch SA, Iwamoto M. McCrea JB, et al. Among authors: zhao t. J Clin Pharmacol. 2019 Oct;59(10):1331-1339. doi: 10.1002/jcph.1423. Epub 2019 Apr 16. J Clin Pharmacol. 2019. PMID: 30990905 Clinical Trial.
Drug-Drug Interaction of Letermovir and Atorvastatin in Healthy Participants.
McCrea JB, Menzel K, Adedoyin A, Cho CR, Fox-Bosetti S, Macha S, Zhao T, Liu F, Panebianco D, Stoch SA, Iwamoto M. McCrea JB, et al. Among authors: zhao t. Clin Pharmacol Drug Dev. 2022 Apr;11(4):420-428. doi: 10.1002/cpdd.1071. Epub 2022 Feb 14. Clin Pharmacol Drug Dev. 2022. PMID: 35157785
Evaluation of the inhibitory effects of itraconazole on letermovir.
McCrea JB, Menzel K, Fancourt C, Witter R, Zhao T, Robbins JA, Stoch SA, Iwamoto M. McCrea JB, et al. Among authors: zhao t. Br J Clin Pharmacol. 2023 Jul;89(7):2122-2130. doi: 10.1111/bcp.15677. Epub 2023 Feb 12. Br J Clin Pharmacol. 2023. PMID: 36717270 Free article.
Assessment of pharmacokinetics, safety, and tolerability following twice-daily administration of molnupiravir for 10 days in healthy participants.
Iwamoto M, Duncan KE, Wickremasingha PK, Zhao T, Liberti MV, Lemoine L, Decaesteker T, Rottey S, Maas BM, Gillespie G, Stoch SA. Iwamoto M, et al. Among authors: zhao t. Clin Transl Sci. 2023 Oct;16(10):1947-1956. doi: 10.1111/cts.13602. Epub 2023 Aug 8. Clin Transl Sci. 2023. PMID: 37526305 Free PMC article. Clinical Trial.
9,506 results